Mannatech, Incorporated

NasdaqCM MTEX

Mannatech, Incorporated EBIT Margin for the Trailing 12 Months (TTM) ending September 30, 2024: -1.47%

Mannatech, Incorporated EBIT Margin is -1.47% for the Trailing 12 Months (TTM) ending September 30, 2024, a 53.56% change year over year. EBIT ratio is the ratio of EBIT to revenue, measuring a company's operating profitability without considering non-operating income or expenses.

Mannatech, Incorporated EBIT Margin for the Trailing 12 Months (TTM) ending September 30, 2023 was -3.17%, a -477.39% change year over year.
Mannatech, Incorporated EBIT Margin for the Trailing 12 Months (TTM) ending September 30, 2022 was 0.84%, a -78.88% change year over year.
Mannatech, Incorporated EBIT Margin for the Trailing 12 Months (TTM) ending September 30, 2021 was 3.97%, a -16.67% change year over year.
Mannatech, Incorporated EBIT Margin for the Trailing 12 Months (TTM) ending September 30, 2020 was 4.77%, a 143.80% change year over year.

Key data

Date	EBIT Margin	EPS (Basic)	EPS (Diluted)	Shares (Basic, Weighted)

NasdaqCM: MTEX

Mannatech, Incorporated

CEO	Mr. Landen Granvel Fredrick
IPO Date	Feb. 16, 1999
Location	United States
Headquarters	1410 Lakeside Parkway
Employees	213
Sector	Consumer Discretionary
Industries Cosmetics Digital Advertising Drugstores & Retail Pharmacies Eyewear Perfumes & Fragrances Personal Care Retail & Wholesale Specialty Retail

Description

Mannatech, Incorporated operates as a health and wellness company worldwide. It develops, markets, and sells nutritional supplements; topical and skin care, and anti-aging products; and weight-management products. The company primarily sells its products directly, as well as through e-commerce and network marketing channels. Mannatech, Incorporated was founded in 1993 and is headquartered in Flower Mound, Texas.

Key trends

Past 5 years